"The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. Each chapter highlights a real, original case study conducted by the authors, including perspectives from executives and employees within each of the thirteen participant companies. Topics covered in this comprehensive survey include considerations for bio-prospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics. It is appropriate for anyone involved in the business, scientific, medical, legal, or regulatory aspects of the biotech, pharmaceutical, and agricultural industries."--Jacket.